Inovio Pharmaceuticals :
INO
INO
Stock Data
$2.06
$0.07 (3.29%)
Asset Type
Common Stock
Exchange
NASDAQ
Currency
USD
Country
USA
Sector
HEALTHCARE
Industry
BIOTECHNOLOGY
Inovio Pharmaceuticals Inc is a biotechnology firm dedicated to creating DNA-based medicines for various diseases, including those linked to human papillomavirus (HPV), cancer, and infectious diseases. Their innovative approach involves designing DNA sequences to target specific antigens and using CELLECTRA devices for efficient delivery. With a focus on clinical studies, Inovio is advancing treatments for HPV-related conditions and diseases like Ebola and lassa fever. Founded in 1983 and based in Plymouth Meeting, Pennsylvania, Inovio collaborates with numerous global partners to push the boundaries of DNA medicine.
All Inovio Pharmaceuticals Articles
52 Articles